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Abstract: Despite the importance of pharmacy practice-based research in generating knowledge
that results in better outcomes for patients, health systems and society alike, common challenges to
PPBR persist. Herein, we authors describe PPBR challenges our research teams have encountered,
and our experiences using technology-driven solutions to overcome such challenges. Notably, limited
financial resources reduce the time available for clinicians and researchers to participate in study
activities; therefore, resource allocation must be optimized. We authors have also encountered primary
data collection challenges due to unique data needs and data access/ownership issues. Moreover,
we have experienced a wide geographic dispersion of study practices and collaborating researchers;
a lack of trained, on-site research personnel; and the identification and enrollment of participants
meeting study eligibility criteria. To address these PPBR challenges, we authors have begun to turn
to technology-driven solutions, as described here.
Keywords: information technology; evidence-based pharmacy practice; health services research;
practice-based research
1. Introduction
Practice-based research occurs in settings where patients typically receive care, and groups of
practices, providers and other healthcare entities often partner with each other and other researchers to
develop practice-based research networks (PBRNs) [1]. Frequently affiliated with academic institutions,
PBRNs draw on the insight of clinicians to identify and frame research questions. By linking these
questions with rigorous research methods in this unique setting, PBRNs produce research findings
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relatively quickly and findings that are relevant and easily translated into everyday practice. Initially
gaining popularity in the mid-1960s within primary care, PBRNs now exist across the world and
focus on various settings, disease states, populations and professions, including pharmacy. As of
February 2020, 186 PBRNs are registered with the United States Agency for Healthcare Research and
Quality, in which six are pharmacist-based and another 72 conduct medication-related research [1].
Pharmacy practice-based research (PPBR) in the United States has potential for continued growth
because Americans take more medications today than ever before, and pharmacists are the healthcare
professionals who are most accessible and the highest trained on medications [2]. Despite PPBRs’
importance in generating knowledge resulting in better outcomes for patients, health systems and society
alike, common challenges persist. Notably, inadequate financial support stunts PPBR by reducing
the time and resources needed by clinicians and researchers to participate in study activities [3,4].
Moreover, PPBR scientists often encounter primary data collection challenges due to unique data
needs and data access/ownership issues. Other well documented barriers to PPBR include (but are
not limited to) the wide geographic dispersion of study practices and collaborating researchers; a lack
of trained, on-site research personnel; and the identification and enrollment of participants meeting
study eligibility criteria [3,4]. To address these challenges, pharmacy researchers have begun to turn to
technology-driven solutions. Herein, we authors from various regions of the United States describe
the PPBR challenges our research teams have commonly encountered, and our experiences using
technology-driven solutions to overcome these challenges. Of important note, we authors assert our
neutrality and neither endorse nor discourage the use of any particular single software program or IT
product; the experiences below are our own and we have no investments, relationships, competing
interests or other conflicts of interest—financial, intellectual or otherwise—with any technology
discussed. Rather, we share our experiences using the technologies available through our respective
institutions and would encourage readers to explore the comparable available technologies for their
own use to address PPBR challenges.
2. Technology Used to Facilitate Pharmacy Practice-Based Research (PPBR)
A summary of the authors’ experiences with using an array of technology to overcome common
PPBR challenges as framed via the Technology Acceptance Model (TAM) is provided in Table 1 and
further described in the sections below [5]. Developed in the 1980s, the TAM has been widely referenced
in the technology acceptance field and used in healthcare for over 20 years [6–10]. It consists of six
constructs, namely external variables, perceived usefulness, perceived ease of use, attitude toward
using, behavioral intention to use and actual system use. We applied select constructs of the TAM,
“perceived usefulness” and “perceived ease of use”, to frame the authors’ experiences with technology.
First, during a conference call, the authors discussed the challenges they encountered during studies in
which one or more members collaborated. From this discussion, a shared Google-Doc file relating
challenges to TAM constructs was developed and the researchers were prompted to individually
expand on their experiences, as well as add any additional challenges/technological solutions they
believed were pertinent. All authors could view and comment on each other’s contributions; summaries
were developed by one author and shared with the group, at which point any discrepancies were
resolved by discussion and consensus.
2.1. Smartphones, Tablets and other Mobile Devices
In our prior PPBR experiences, we authors found that mobile devices (e.g., smartphones, surfaces
and tablets) are important to practice-based research because they are often fundamental to the use of
other technology, including the technology-driven solutions described within this manuscript. Indeed,
mobile devices have been used to facilitate an innumerable range of interventions, including everything
from direct patient care and monitoring, to inter-professional communication and collaboration;
however, mobile devices’ utility in PBRN research extends far beyond intervention delivery [11,12].
For example, we authors experienced that the identification, recruitment and enrollment of patient
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subjects is particularly challenging in community-based PPBR because community pharmacists’
services in the United States are rarely provided on an appointment basis. Rather, as the most accessible
healthcare provider, U.S. community pharmacists more often provide care on a walk-in basis, leaving
researchers unable to predict when potential patient subjects will present [13,14]. Moreover, we found
PPBR challenging often due to the lack of resources required to physically position trained research
personnel on-site at remotely located study locations. In response, not only have mobile devices and
other handheld technologies shown promise in coordinating/training research personnel (as described
in several sections below) but have also facilitated PPBR by their use in informed consent processes [15].
The authors used guidance for obtaining informed consent via electronic processes (i.e., electronic
informed consent or ‘eIC’) issued by the U.S. Department of Health and Human Services (HHS)
Office for Human Research Protections (OHRP) and the Food and Drug Administration (FDA),
and as such, have utilized these practices to overcome the identification, recruitment and enrollment
challenges. For example, handheld devices utilizing Research Electronic Data Capture (REDCap)
e-form software (as further described below) allowed the authors to perform subject consent off-site
and capture electronic signatures. For example, e-consent processes were used in Snyder et al.’s recent
usability-study that video-recorded pharmacists as they prepared to deliver comprehensive medication
review (CMR) services to patients. To do this, authors first obtained a ‘waiver of documented consent’
from the university’s Institutional Review Board (IRB) which allowed authors to speak with patients
by phone prior to the patient’s CMR appointment. During this call, authors explained the study and
obtained the patient’s verbal consent for authors to video-record their pharmacists as they prepared
for the patient’s upcoming CMR appointment. Then, once the patient appeared at their community
pharmacy for their CMR appointment, the patient watched a pre-loaded video on a study iPad that
reviewed the consent and HIPAA authorization documents. After watching the video, the patient was
navigated to REDCap, where pre-loaded consent documents allowed patients to ultimately provide
authors with written consent [16]. This technology can also be useful for researchers seeking to
enroll non-English speakers when no on-site translation services are available. Specifically, as part
of the authors’ ongoing PPBR study, on-site research personnel use handheld devices to access
e-forms/surveys (as described below) containing brief translated recruitment materials and scripts for
making telephone contact/hand-offs to off-site translators [15].
Despite their helpfulness, we have encountered several limitations to the use of mobile devices in
PPBR. First, mobile devices’ most recognizable benefit to PPBR—their portability—is limited because
the devices are often expensive and fragile. Researchers must not only invest in the devices themselves,
but also anti-theft and protection software and accessories. Their mobility is especially challenging
because the more they are used, the more they risk breakage and loss. Similarly, their increased risk of
loss compared to the traditional desktop makes mobile devices more likely to cause data breaches.
Furthermore, devices must receive regular maintenance and care, like charging, software updates,
and virus protection, as well as device replacement after a period of time; this results in ongoing costs.
Lastly, the use mobile devices in PPBR is challenging because researchers must be knowledgeable
and comply with a litany of regulation. Not only must the use of mobile devices comply with the
researchers’ respective university IRBs, but also many federal and state regulations. The protection of
private health information under HIPAA is the most notable regulation, but researchers interested in
using or developing mobile technology for PPBR should also be aware of the regulations of the U.S.
Federal Trade Commission (FTC). Despite these challenges, we authors plan for the continued use of
mobile devices to facilitate PPBR because they are helpful not only with the identification and consent
of patients, but also with data collection and research team communication/training, as described in
the following sections.
2.2. Electronic Form and Survey Software
The authors used several electronic tools to develop and deploy novel electronic data collection
forms (i.e., e-forms/surveys) [4,16–23]. In our experiences, we found that these ‘e-form/survey’
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programs required little-to-no informatics training and were often accessible via desktop computers,
tablets and other mobile devices alike. Basic features allow researchers to create items such as fill-in the
blank, single–multiple choice and “select all that apply” questions, whereas more advanced features
can apply skip-logic, auto-validate data, or calculate fields. E-form/survey programs are usually housed
on a server, so no extra downloads are required and researchers’ data can be subsequently stored on
that server. Server-stored data can then be downloaded in files compatible with the analysis programs
such as Excel, SPSS Statistics or R-software. In addition, we found that e-form/survey programs often
have off-line features that allow researchers to collect data without an internet connection.
While many different e-survey platforms exist, and we in no way endorse or discourage the
use of any single product, we researchers have had the most experience with REDCap, the Research
Electronic Data Capture tool [24]. Developed in 2004 by Vanderbilt University with support from
the U.S. National Institutes of Health, REDCap l was created to facilitate the design of clinical and
translational research databases [24]. Specifically, the developers aimed for REDCap to support small,
investigator-initiated studies via a user-friendly interface and as such, the tool has been used in
studies around the world [24]. Accordingly, we found that REDCap was specifically useful for PPBR
because the development, testing, launching and utilization of data collection databases requires
little-to-no IT/informatics specialists’ support. REDCap allowed us to import common data collection
tools (i.e., validated surveys and instruments) as well as share novel data collection forms with other
institutions. The software is distributed to institutional partners at no cost but is neither open source,
nor permitted for commercial purposes; as such, we encountered instances where we were charged
small fees to cover the cost of the internal IT support staffing. Another e-form/survey software program
we commonly used was developed by a private corporation, Qualtrics LLC. Like REDCap, we found
that the Qualtrics software allows researchers to disseminate e-forms/surveys via hyperlinks and can
present simple reports (i.e., descriptive statistics) on entered data.
We found that other e-form/survey platforms were usually accessible to pharmacy researchers
via their academic institutions at little-to-no cost. These e-form/survey platforms may also offer free,
publicly available versions online via vendors like SurveyMonkey, or Qualtrics, or free versions via
social-media companies like LinkedIn and Facebook. However, we found that even if a certain vendor’s
e-form/survey software is accessible, free and/or used by other organizations/universities for their
research programs, that our own institutions may not necessarily contract with these vendors as well.
Assuring that a vendor’s program is contracted with our respective university is important because we
found that free and contracted versions of software programs may have various features. For example,
we found that while publicly available e-forms/surveys may offer HIPAA-compliant features and
may state that they comply with international privacy laws like the European Union’s General Data
Protection Regulation (GDPR), federal privacy regulation in the United States has not kept pace with
the rate of technology’s advancement and accessibility [25]. As such, any researcher interested in using
e-form/survey platforms should know that free and contracted versions may have different levels of
protection. Furthermore, while publicly available e-forms/surveys are seemingly “free to use,” data
access and ownership issues remain. Specifically, whereas publicly available e-form/survey programs
may allow researchers to use their software without costs, we have encountered instances where data
collected has been kept behind a paywall. Collectively, we authors found the greatest success when we
utilized our university-contracted software rather than free-to-use versions and encourage other PPBR
study teams to regularly check with their respective organizations/university’s IT department before
choosing a product for their project.
We used several other ubiquitous software programs, like Microsoft Excel and Access, as they are
commonly used by health-systems and clinicians alike to collect data [26]. However, we experienced
that e-form development on Access and Excel requires a moderate level of skill, and data entered directly
into Excel can be prone to data-entry errors, over-writing and erroneous deletion. Conversely, we have
found that the REDCap and Qualtrics programs offer features like data validation, force-functions and
data repositories that decrease the likelihood of such data-collection mistakes. Overall, we found that
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the use of e-form/survey programs facilitated PPBR in a wide variety of methods, subjects and settings
and are particularly helpful to conduct surveys and collect data [15,16,23,27].
2.3. Video/Audio-Recording Devices and Software
Traditionally, we authors have relied on digital recorders, tape-recorders and our own hand-written
notes to collect study participants’ words and actions. Today, we are beginning to use digital applications
designed for desktops and mobile devices, like Dragon, Google Voice and InfraWare Dictation (InfraWare
Inc.) to record video and audio data. Several of the authors have used HIPAA-compliant versions
of these applications to record semi-structured interviews, focus-groups, contextual inquiries and
investigator observations in past and current PPBR research projects [15,23,28–30]. While Dragon and
Google Voice use artificial intelligence to transcribe recordings, the InfraWare records dictation via
smart-phone, computer, or tablet for the researcher to upload to the application’s web-based platform
for human transcription.
Our experiences using the InfraWare software for PPBR were mainly positive, but we are neither
endorsing nor discouraging its use. As a cloud-based application, we found that we needed neither
cellular data nor Wi-Fi to use InfraWare Dictation’s features because users can record audio data
without internet and later upload data to the platform when connectivity is re-established, minimizing
the risk of data breaches. Once uploaded, the InfraWare Dictation’s platform provides a secure venue
for healthcare transcriptionists to transcribe audio files, which can be subsequently downloaded as
a Word, RTF or PDF file. Upon logging into the application’s portal, all of our audio recordings,
transcripts and progress on partially transcribed files are viewable. While we authors were able to
download the InfraWare Dictation application for free (eliminating the need for researchers to purchase
HIPAA-compliant recording devices), transcription services were associated with a cost, which we
found could be prohibitive for some studies. We found that the application generally required no
more skill than using hand-held audio devices, and we were supported by online training videos, user
guides and a designated support contact for our respective university. However, we found that pausing
and restarting recordings was complicated by mobile notifications. As such, we found we could avoid
the risk of unintentionally stopping a recording in InfraWare Dictation by placing recording devices in
airplane mode.
In addition to facilitating data collection and subject recruitment, we found that mobile audio/video
devices, like GoPros, have shown promise in training research personnel, especially for personnel
working at off-site study locations. GoPros, and other handheld recording devices, are usually small,
wearable, light-weight audio/video cameras that are often purchased with proprietary video-editing
software. We found that these hand-free devices allowed trainees to watch and listen to pre-recordings
of trainers performing a wide range of research activities conducted in the first-person (i.e., protocol
activities, data collection, recruitment processes and administrative duties). Similarly, videos can
convey spatial and process information more quickly than written instructions and can be especially
helpful for research projects that have multiple, temporary, or off-site personnel. For example, some of
the authors used GoPro training videos to facilitate PharmD students’ integration in PPBR. Specifically,
our ongoing research examines how PharmD students, in their final year of advanced pharmacy
practice experiences (APPEs) could act as pharmacist-extenders in delivering transitions of care
services over a period of two months [31,32]. In addition to assisting pharmacists in delivering the
standard intervention, the students were also tasked with collecting and entering the study data in
this practice-based project. Video recordings made on GoPros and other hand-held devices helped to
quickly train students step-by-step on research protocols as they rotated in and out of the study and
helped reduce variability in the research project’s functions.
However, while GoPro training videos can last as enduring education and can help facilitate the
training of multiple research personnel that rotate through studies, we found that their usefulness
diminishes in relation to how frequently a study’s protocol updates. Similarly, researchers must have
both access to and working knowledge of video-editing software, as well as recording accessories
Pharmacy 2020, 8, 93 6 of 14
like microphones, SD cards (for memory storage) and USB cables. The prices of hand-held recording
units can widely vary as well, with less expensive units costing less than a hundred dollars and
more expensive units exceeding thousands of dollars. Another example worth noting is that we have
collected high-quality audio-recordings with inexpensive key chain recorders for pharmacy secret
shopper data collection, [33]. The recordings from these keychains were then uploaded to Box, a private
data storage server following university-approved HIPPA procedures [33].
2.4. Desktop Capture Software
We found that desktop capture software proved useful in facilitating PPBR data collection and
training research personnel [16,23]. Potentially available through researchers’ organizations/universities,
desktop capture software can be still (i.e., capture of a single screenshot image), or dynamic
(i.e., recording screen movement over a period of time). Still desktop capture software, like HyperSnap,
enables the capture and editing of high-quality Windows screenshots. Resembling Windows Paint, this
software is easy to use and requires little training. HyperSnap is specifically useful to PPBR, because
of its ability to protect protected health information (PHI) as once black boxes are placed and saved
on screenshots, it is unable to be moved or deleted. This function can help prevent the accidental
disclosure of HIPAA-protected information through unintentional editing of the file. As an example
of HyperSnap’s use in PPBR, HyperSnap was used by the authors to study how clinical decision
support (i.e., alerts/flags) for medication therapy management (MTM) was designed and delivered in
community pharmacy practice. We researchers trained pharmacists to capture screenshots of MTM
alerts using HyperSnap as they worked up patients in their everyday practice. Pharmacists were
able to redact patient identifiers to ensure patient confidentiality, and then submit screen shots to us
investigators for analysis. The results of this research were applied to develop recommendations for
MTM clinical decision-support redesign to aid more effective care delivery [16,23].
Contrary to still desktop capture software, we found that dynamic desktop capture programs,
like MediaSite, Morae and Kaltura, allow researchers to record screen movements. Because users
can record audio along with screen movement, organizations/universities often make these programs
available to academics for recording lectures and class sessions. However, in addition to being useful
as a teaching aid, we found that dynamic desktop capture software can also prove useful in developing
training videos for research personnel, especially for training in other technologies described in this
paper, like e-forms/surveys software [31]. However, we experienced that the drawbacks of using
dynamic desktop capture software to create training materials mirrored the same drawbacks of using
video recording software, including editing challenges [31].
Furthermore, we found that dynamic desktop capture software can be useful in facilitating
usability studies. For example, when used in conjunction with web-conferencing software (e.g., WebEx,
as described below), pharmacist-study participants in our MTM alert study were able to share their
real-time, computer work with researchers, who in turn were able to record the user’s on-screen
interaction via Morae [16]. This technology was also used in combination with video/audio recording
software (i.e., computer-based webcams) to allow us researchers to record participants’ faces and
reactions to using software as they “thought aloud.” As such, this is just one example where several
different technologies can be used synergistically.
2.5. Web-Conferencing and Group-Messaging Applications
We found that electronic-communication technologies, like web-conferencing applications
(e.g., Skype, WebEx, Zoom, FaceTime) and group-messaging applications (e.g., WhatsAPP, GroupMe)
can be helpful in maintaining coordination among remote study sites [31,32]. Keeping all the key and
non-key personnel abreast of study-related activities is a common challenge to PBRN research as study
sites and team members are physically distant from each other; e-communication applications directly
address this challenge and offer several benefits over traditional communication techniques. In addition
to features like complete end-to-end security, unlimited sessions/messages, and e-invites/reminders,
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we found that e-communication applications offer researchers benefits because they are accessible via
a variety of sources like desktops, smartphones, tablets and other mobile devices. Moreover, we found
that e-communication applications are often free, user friendly, require minimal set up and can be used
by many participants simultaneously [31].
We found that web-conferencing applications’ most notable benefit beyond typical conference
calls is their ability to facilitate face-to-face communication; this is particularly important as
face-to-face communication is known to increase team-member satisfaction and a sense of unity
beyond non-face-to-face communication. Applications like Skype, WebEx and FaceTime can also
be used to facilitate semi-structured interviews and focus groups because unlike typical conference
calls, web-conferencing applications often allow users to share their on-screen view, record calls
and exchange documents. Similarly, compared to typical emails, we found that group-messaging
applications’ most notable benefit is their ability to spread information quickly and in real-time among
multiple people, without multiple long email-chains. Group-messaging applications can also show
read receipts with time-stamps, and may provide faster, more concise responses than email [31].
Despite providing researchers with multiple benefits, web-conferencing and group-messaging
applications are not without their drawbacks. Firstly, the applications require devices with internet
connection, and conferencing sessions require devices with audio and video functions. Similarly, while
applications rarely limit users on the number of conferences/messages sent, some free versions may limit
the time conferences may last or the number of participants. Furthermore, we found that if research
personnel communicate via group-messaging applications, but are not issued work-related cellphones,
personal devices must be used; multiple group-messaging replies—like email—can become a nuisance.
More concerning, however, web-conferencing and group-messaging applications present privacy
concerns, as users must accept the Terms of Use without HIPAA-compliant levels of privacy guaranteed.
2.6. Data Storage and File Transfer Programs
Typically, organizations/universities provide researchers with secure, password-protected servers,
platforms and encrypted email programs that allow them to store data securely and share/collaborate
on files with individuals from their own institution (e.g., Microsoft Office applications). However, we
encountered challenges when attempting to transfer, share or collaborate on files with other individuals
outside of our universities or use platform-based technology that remotely stores data (e.g., InfraWare).
Specifically, we recognized that emails cannot transfer large files, and flash drives risk data losses
and breaches of confidentiality. Similarly, while publicly available web-based file storage and sharing
platforms like Google Drive and Dropbox are available to researchers for free, we found that they may
offer little security unless individually contracted with our respective university. To address these
challenges, we authors used file transfer programs (FTPs) which are web-based programs that provide
short-term storage and encryption specifically for secure file transfer.
One example of an FTP we used is FileLocker. FileLocker was developed at Purdue University
but is available among multiple universities worldwide [34]. The application provides encryption and
is compliant for sharing HIPAA- and FERPA-protected files alike. Researchers may use FileLocker
to request files from public users and create distribution accounts that other users can access; these
features are particularly helpful when transferring protected data among institutions, or to approve
outside third parties. For example, in our previous research we used FileLocker to exchange identifiable
audio-recordings and transcripts between universities and private transcription service companies [35].
FileLocker also provides an extra level of security above and beyond traditional data-sharing methods
as it allows researchers to audit user activity.
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3. Challenges of Using Technology in Pharmacy Practice-Based Research
Despite technology’s ability to facilitate PPBR, we experienced unintended consequences,
challenges and limitations to its implementation (Table 2). We found that these challenges require
investigators to work closely with their institutions’ regulatory and/or information technology teams
to ensure the successful use of technology in PPBR. Firstly, the use of technology raises concerns
about privacy, especially that of protected health information (PHI). We urge other researchers to not
only read and understand a vendor’s privacy statements, but also be aware that vendors reserve the
right to revise these agreements upon notice. Furthermore, no technology is immune from unwanted
interception by third parties. As such, we suggest that researchers using any web or electronic
platform to collect, store, transmit or otherwise handle data should be careful not to make guarantees
of confidentiality or anonymity. Rather, researchers should be transparent during informed consent
about the limits of confidentiality. Similarly, we suggest that researchers can protect privacy by either
removing identifiable data entirely or otherwise separating identifiers from data and linking the two
with unique study identifiers and/or code-keys. Code-keys should be stored independently and
separately from any corresponding identifiable information and study data.
Table 2. Authors’ experiences overcoming the challenges of implementing technology-driven solutions
in pharmacy practice-based research.
Major Lesson Experiences Overcoming Implementation Barriers
Contact Institutional Review




• Academic institutions usually have preferred software programs and
these are often available to PPBR researchers for little to no-charge and
may offer extra features, security, and/or support.
• Avoid publicly available software programs, as paywall and privacy
issues may arise.
• Academics may save effort obtaining IRB approval if utilizing their
institution’s preferred software, as IRB members will likely be familiar
with such preferred programs.
• Software programs may assert HIPAA compliancy; however,
researchers may save time and undue delays by contacting IRBs before
developing protocols.
• Development and maintenance of positive working relationships with
IT departments is crucial; IT personnel should be consulted before
using any new software and notified of any changes.
Prepare for Technologies’
Limitations.
Take Redundant Efforts to
Protect e-Data.
• Develop back-up protocols with traditional resources.
• Avoid breaches and data loss file-monitoring and protection software
and regularly deploy antivirus and malware programs. Maintain the
latest versions of vendor-supplied security patches.
• Read technology vendors’ Terms of Use and/or Privacy Policies before
choosing products and cite these documents in IRB applications. Be
aware of any clauses that allow vendors to change Terms and Policies,
and how they may be changed.
In addition to privacy concerns, researchers may face challenges understanding, applying for—and
complying with—institutional review boards (IRBs) when attempting to use technology in their studies.
Studies using technology for human subject research must be approved by IRBs, be HIPAA-compliant
and comply with all the U.S. Department of Health and Human Services’s Protection of Human Subjects
federal regulations, just like any other research. Therefore, researchers are responsible for explaining to
their IRBs how the proposed technology provides the same level of protection as traditional methods.
Researchers should be able to easily find these explanations in plain language in technology vendors’
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Terms of Use; if, however, such language is neither present nor readily understandable in the Terms of
Use, researchers may take heed of using that technology in favor of another option.
The integration of technology in PPBR is also challenging because electronic data files can
become corrupt. Years of researchers’ work can be immediately invalidated by malware, viruses,
physical damage or by the simple aging of obsolete software. Saving multiple copies of files on
independent platforms, servers and drives reduces the risk of data loss, but this practice inversely
increases the risk of a loss of privacy through data breach. Conversely, researchers may be wary
of using technology in research because electronic deletion is neither readily visible nor verifiable.
Furthermore, once researchers utilize a certain technology, they must then rely on an uncontrollable
entity (i.e., technology vendors) to continue to support and maintain that product. In other words,
most technology vendors are private businesses, and therefore reserve the right to change, or discontinue
any service or product they produce. Naturally, researchers can be uncomfortable with this dependence.
Indeed, PPBR activities are limited by a lack of adequate resources, and researchers with low-technology
skills (either actual or perceived) may then further shy away from using technology as little IT resources
may be available to offer support.
Technology’s usefulness in facilitating PPBR is also limited because sometimes the technology
itself is simply not well advanced. For example, the InfraWare Dictation recording and transcription
application utilizes professional human transcriptionists to transcribe audio recordings to text. While
artificial intelligence dictation tools exist, we authors found in our research that these technologies are
not advanced enough to reliably and correctly transcribe audio-recordings. Naturally, voice recognition
software is expected to advance to a point where it will be regularly helpful in PPBR because most
technology tends to advance at an exponential rate. However—regardless of technology’s future
advancement and ability to facilitate PPBR—its use will likely remain challenging because advancement
and cost go hand in hand. As such, there is a lag period between when a new technology is developed
and when it becomes readily accessible.
An example of this lag period’s negative effect on PPBR is represented by internet accessibility;
the lack of wireless internet access is a known challenge to conducting PPBR. Wireless internet was
first demonstrated in 1971, but many community pharmacies have neither internet nor Wi-Fi, choosing
rather to rely on intranets (i.e., networking and sharing systems that resemble the internet, but are
bound to a single entity). Costs and dissemination/implementation challenges are not the only reason
why community pharmacies often utilize intranet over internet. Pharmacies may restrict internet
access to employees for security or productivity reasons. Consequently, some PPBR challenges related
to human factors may continue to exist regardless of technology’s advancement, costs and accessibility.
4. Discussion
Here, we authors presented our experiences and lessons learned in applying technology-driven
solutions to overcome common PPBR challenges. From these experiences, we believe that the
benefits and unintended drawbacks of technology’s integration into health systems may oscillate,
but that ultimately technology’s role in healthcare will only continue to become more vital. Indeed,
American pharmacies universally rely on computerized systems to dispense medications and deliver
innovative services. As such, we hope to share these experiences so that other pharmacy academics
can capitalize on technologies to overcome common practice-based research barriers, such as research
team coordination, unique data collection needs and privacy concerns.
Given enough time, it seems plausible that technology could eventually address most PPBR
barriers because technology ‘grows’ at an exponential rate. For example, the old adage ‘Moore’s Law’
states that circuit transistors double every two years. Furthermore, promising tools like machine
learning and artificial intelligence have the potential to greatly improve future academics’ utilization
and understanding of PPBR. However, technology is not likely to become the ultimate liberator
for pharmacy practice-based researchers’ challenges (at least in this era) because many challenges
either relate to or stem directly from social, economic or human factors. For example, one of the
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most visible and well known barriers to PPBR is the need to minimize workflow disruptions as sites
continue to deliver their regular services [36]. PPBR research sites primarily exist to deliver health
services, and are not sterile, controllable environments that are readily primed to carry out research;
so, while technology-driven solutions can reduce workflow disruptions caused by traditional PPBR
methods, we believe that these solutions often create other workflow concerns. Respect for our
pharmacy colleagues’ work realities and priorities will continue to be at the center of our successful
PPBR collaboration.
We believe that another PPBR barrier unlikely to be overcome with technology in the near
future is the discipline’s inability to perform meaningful systematic reviews and meta-analysis on
pharmacist-provided services. Ideally, advancements in artificial intelligence (AI) are predicted
to assist researchers perform meta-analysis/systematic review by identifying suitable articles,
collecting/analyzing data and examining sources of heterogeneity between studies. However, it is likely
that if (or when) any such AI is developed, PPBR academics will continue to face challenges completing
systematic reviews and met-analysis of pharmacy practice services because of the misuse, confusion
and variable use of pharmacy practice service terminology in the literature. Little standardized MeSH
(Medical Subject Headings) terms exist that readily encompass modern pharmacy practice, especially
regarding community-based services, and the profession has adopted no universal definitions for its
services [37]. Accordingly, PPBR researchers will likely need to wait until the AI is advanced enough
to understand subtitles in human language patterns and analogies for assistance in systematic reviews
and meta-analysis [38].
Indeed, as this paper attempted to outline, our experiences have shown that technology’s use
in facilitating PPBR appears as a double edged sword (Table 1); whereas technology may assist in
overcoming a barrier, a new concern is raised. As such, while technology can facilitate the speed
of data collection and transfer, privacy concerns are raised. Similarly, while researchers have more
technological solutions to choose from than ever before (and new products being developed rapidly),
laws, regulations and researchers’ comfort using such technology may not keep the pace. Ultimately,
it is almost certain that clinicians and researchers will continue to use technology, and that this use
not only provides unique research opportunities for academics, but also to propel the profession of
pharmacy forward.
5. Limitations
This paper is limited because the experiences presented are merely our own and do not necessarily
represent others’ experiences with the same or similar technology. As such, all authors’ experiences
took place within the United Stated circa 2010–2020, so the lessons learned in implementing these
technology-driven solutions are less applicable to researchers outside of the United States. Similarly, this
paper’s applicability will most likely diminish as time progresses, as newer versions of technology and
strategies to implement those technologies are made. Furthermore—as the experiences presented are
only our own—we make no guarantee, endorsement of, nor discourage the use of any singular product.
Furthermore, we authors do not claim to be pioneers in the use of these technologies in overcoming
PPBR challenges. Conversely, the tools we reported on here were brought to our attention initially
because they held pre-existing reputations among research communities, and we emphasize that we
simply used specific products as they were available at our universities; comparable products available
elsewhere could likely be explored and used too. Therefore, many specific technologies, products or
tools were never mentioned or considered as they were not used by the authors.
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